Funds holding AKTIS ONCOLOGY INC
ISIN US01021M1045 · United States
- Fund holders
- 108
- Of which ETFs
- 15 93 other funds
- Value held
- 195.9M $
- Share of capital
- 13.1 % of 53.4M shares on Jun 30, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| PROFUND VP SMALL CAP ProFunds | 57 | 1.8K $ | 0.02 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Russell 2000 Fund Rydex Series Funds | 53 | 1.7K $ | 0.01 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 37 | 1.2K $ | 0.03 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 31 | 999.1 $ | 0.01 % | 0.00 % | as of Jun 30, 2026 ↗ |
| ProShares Hedge Replication ETF ProShares Trust | 19 | 394.1 $ | 0.00 % | 0.00 % | as of May 31, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 18 | 397.3 $ | 0.00 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 6 | 193.4 $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 6 | 124.4 $ | 0.01 % | 0.00 % | as of May 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Meridian Small Cap Growth Fund Meridian Fund Inc | 1.25 % | as of Jun 30, 2026 ↗ |
| Eventide Healthcare & Life Sciences Fund MUTUAL FUND SERIES TRUST | 0.91 % | as of Jun 30, 2026 ↗ |
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 0.67 % | as of Jul 31, 2026 ↗ |
| Polen 5Perspectives Small Growth Fund FundVantage Trust | 0.53 % | as of Jul 31, 2026 ↗ |
| T. Rowe Price Small-Cap Stock Fund, Inc. T. ROWE PRICE SMALL-CAP STOCK FUND, INC. | 0.23 % | as of Jun 30, 2026 ↗ |
| T. Rowe Price Institutional Small-Cap Stock Fund T. Rowe Price Equity Funds, Inc. | 0.23 % | as of Jun 30, 2026 ↗ |
| T. Rowe Price Health Care ETF T. Rowe Price Exchange-Traded Funds, Inc. | 0.21 % | as of Jun 30, 2026 ↗ |
| Health Sciences Portfolio PACIFIC SELECT FUND | 0.14 % | as of Jun 30, 2026 ↗ |
| Select Biotechnology Portfolio Fidelity Select Portfolios | 0.11 % | as of May 31, 2026 ↗ |
| BlackRock Health Sciences Opportunities Portfolio BlackRock Funds | 0.09 % | as of May 29, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 108 | +23 | 7,028,006 | -0.0 % |
| 2026Q2 | 85 | +81 | 7,030,837 | +337.7 % |
| 2026Q1 | 4 | 1,606,406 |
Institutional managers
65 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| MPM BIOIMPACT LLC | 4,835,872 | 86.5M $ | as of Mar 31, 2026 |
| EcoR1 Capital, LLC | 4,824,469 | 86.3M $ | as of Mar 31, 2026 |
| Blue Owl Capital Holdings LP | 3,161,348 | 56.6M $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 2,317,044 | 41.5M $ | as of Mar 31, 2026 |
| T. Rowe Price Investment Management, Inc. | 2,123,812 | 38K $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 2,112,127 | 37.8M $ | as of Mar 31, 2026 |
| RTW INVESTMENTS, LP | 1,592,043 | 28.5M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1,564,196 | 28K $ | as of Mar 31, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | 1,503,084 | 26.9M $ | as of Mar 31, 2026 |
| JANUS HENDERSON GROUP PLC | 1,454,267 | 26M $ | as of Mar 31, 2026 |
| BAKER BROS. ADVISORS LP | 996,351 | 17.8M $ | as of Mar 31, 2026 |
| Octagon Capital Advisors LP | 960,847 | 17.2M $ | as of Mar 31, 2026 |
| Merck & Co., Inc. | 952,844 | 17M $ | as of Mar 31, 2026 |
| EVENTIDE ASSET MANAGEMENT, LLC | 507,000 | 9.1M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 491,936 | 8.8M $ | as of Mar 31, 2026 |
| Avidity Partners Management LP | 468,566 | 8.4M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 428,253 | 7.7M $ | as of Mar 31, 2026 |
| a16z Capital Management, L.L.C. | 415,000 | 7.4M $ | as of Mar 31, 2026 |
| FMR LLC | 386,379 | 6.9M $ | as of Mar 31, 2026 |
| UBS Group AG | 353,263 | 6.3M $ | as of Mar 31, 2026 |
| ArrowMark Colorado Holdings LLC | 329,471 | 5.9M $ | as of Mar 31, 2026 |
| Alyeska Investment Group, L.P. | 290,000 | 5.2M $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 162,017 | 2.9M $ | as of Mar 31, 2026 |
| Driehaus Capital Management LLC | 150,000 | 2.7M $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 149,476 | 2.7M $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Funds holding AKTIS ONCOLOGY INC". https://titelia.com/en/stocks/aktis-oncology-inc-US01021M1045